Back

Clinical risk factors and P wave indices in prediction of atrial fibrillation development during long-term follow-up after acute ST-segment elevation myocardial infarction.

28 August 2021 (20:33 - 20:42)
Organised by:
Congress Presentation Part of: Atrial fibrillation: the role of risk markers Prevalence and Incidence of Atrial Fibrillation ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Maria Baturova

Lund (Sweden)

2 More presentations in this session

Presentation thumbnail
Risk of atrial fibrillation in young adults aged 20 to 39 years with isolated diastolic, isolated systolic, and systolic-diastolic hypertension: a nationwide population-based study
Doctor S. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Dynamic changes of cardiovascular biomarkers after ablation for atrial fibrillation: Observations from AXAFA-AFNET5.
Doctor W. Chua (Birmingham, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: the role of risk markers

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 20:33 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic markers of atrial fibrillation after stemi
2 March 2019
thumbnail
Congress Presentation
Left atrial assessment improves prediction of incident atrial fibrillation beyond CHARGE-AF risk score
13 December 2024
thumbnail
Congress Presentation
P-wave duration and interatrial block as predictors of new-onset atrial fibrillation: A systematic review and meta-analysis
16 April 2023
thumbnail
Congress Presentation
Development of a clinical risk score for early left ventricular thrombus prediction following anterior ST-segment elevation myocardial infarction
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources